Complete Heart Block, Found Incidentally: Permanent Pacing or a Reversible Cause First
A single patient with a device-grade diagnosis found on a form meant to clear him for a new job, and a detail in his history that raises a real question of whether the block itself might not be permanent. The disagreement is about whether to test that possibility before committing him to a lifetime device.
N.P., a 34-year-old man, works as a landscaper and spends most of his summer in yards and wooded lots across the region. About three weeks ago he had a few days of fever, fatigue, and a rash he assumed was an ordinary bug bite reaction and never had looked at. He came in this week only because a new employer required a pre-employment physical, and the ECG performed as part of that routine screening showed complete heart block — no electrical connection at all between his atria and ventricles, his ventricles sustained only by a slow but narrow-complex junctional escape. He has no symptoms: no syncope, no dizziness, no exertional limitation he's noticed.
Complete heart block is, on its own, a definite indication for a pacemaker, symptoms or not, given the real risk of syncope or sudden death from an unreliable escape rhythm. But his history — outdoor work, a fever-and-rash illness several weeks earlier that he never sought care for — raises a real, testable alternative: Lyme carditis, which can produce exactly this degree of AV block and, unusually among causes of complete heart block, can fully resolve with antibiotic treatment within days to weeks. It is not the only reversible cause — drug toxicity, hyperkalemia, acute ischemia, and post-operative block all resolve too — but it is the one his history actually points to. A 34-year-old committed to a permanent device carries that device, and its lifetime of lead revisions and generator changes, for a very long time if the underlying cause never actually needed one. He remains entirely asymptomatic on continuous monitoring, with a stable escape rhythm holding his heart rate in a survivable range while the team works out which path actually serves him.
A device-grade finding with a testable alternative
Complete heart block is a definite pacing indication on its own, and I don't think a possible reversible cause changes that enough to skip the device entirely. Even if Lyme carditis is confirmed and treated, resolution isn't guaranteed or immediate, and I'm not comfortable leaving a 34-year-old with no reliable AV conduction unprotected while we wait to find out.
I'm not proposing we leave him unprotected — I'm proposing we don't commit him to a permanent device before we've genuinely tested whether this needs one at all. His exposure history and untreated illness fit Lyme carditis closely, and it's one of the few causes of complete heart block that resolves outright with treatment rather than merely improving. A 34-year-old carries a permanent pacemaker for potentially fifty years of lead revisions and generator changes — that's worth a real attempt to rule out a reversible cause first, provided we protect him properly while we do.
"Provided we protect him properly" is doing real work in that sentence, and I agree it has to mean more than a promise — it means a temporary pacing solution while treatment is underway, not an outpatient antibiotic course and a wait-and-see ECG in a month.
That's the actual plan that resolves both concerns: temporary pacing now, for genuine protection while his rhythm is unreliable, alongside intravenous ceftriaxone, 2 g once daily, for presumptive Lyme carditis given his exposure history and illness pattern, without waiting for serologies to result before starting treatment; once his conduction recovers he steps down to oral doxycycline to finish a two-to-three-week course. If his AV conduction recovers over the following one to two weeks, as it does in a real share of Lyme-associated complete heart block, the temporary system comes out and no permanent device is needed. If it doesn't recover, the permanent pacemaker conversation resumes from a position of actually having tried, not skipped, the reversible explanation.
Temporary pacing placed for protection; intravenous ceftriaxone started presumptively for Lyme carditis rather than waiting on serologies. Permanent pacemaker decision explicitly deferred, with a one-to-two-week reassessment of his intrinsic AV conduction planned before revisiting it.
Temporary system removed, no permanent device needed.
Permanent pacemaker proceeds, informed by having genuinely tried the reversible explanation first.